abstract |
The present invention relates to fibronectin-based backbone proteins that bind to PCSK9. The invention also relates to the use of novel proteins in therapeutic applications for treating atherosclerosis, hypercholesterolemia and other cholesterol-associated diseases. The invention further provides cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and vectors comprising polynucleotides encoding the novel proteins. |